Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Summary

This is a randomized, double blind placebo controlled study to evaluate safety and efficacy of lucanthone administered as an adjunct to patients receiving whole brain radiation therapy (WBRT) as primary treatment for brain metastases secondary to non-small cell lung cancer.

Timeline

Start

2016-01

Primary completion

2017-11-29

Completion

2017-11-29

Outcome

Outcome not reported

Stopped: “Pending resolution of study drug issues”

Drugs

Indications